awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30730505-3E252859-31E6-41EE-BFC5-0FDDBC02D8DE
Q30730505-3E252859-31E6-41EE-BFC5-0FDDBC02D8DE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30730505-3E252859-31E6-41EE-BFC5-0FDDBC02D8DE
The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis.
P2860
Q30730505-3E252859-31E6-41EE-BFC5-0FDDBC02D8DE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30730505-3E252859-31E6-41EE-BFC5-0FDDBC02D8DE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7c4cb7842cfd07d27ee5e9e570f8fb316b6c1edd
P2860
IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.